Covered recipient · General Payments record
DONALD J FORNACE
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$1,766.54
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $527.99 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $242.82 | 12 |
| Lilly USA, LLC | $151.35 | 4 |
| Novo Nordisk AS | $75.36 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $30.79 | 2 |
| E.R. Squibb & Sons, L.L.C. | $27.67 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $9.19 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111576488 | CMS |
| Amgen Inc. | $12.02 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111576490 | CMS |
| Amgen Inc. | $7.59 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111576492 | CMS |
| Amgen Inc. | $11.65 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111576494 | CMS |
| Amgen Inc. | $10.92 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111576496 | CMS |
| Amgen Inc. | $13.55 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111576498 | CMS |
| Amgen Inc. | $17.13 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111576500 | CMS |
| Amgen Inc. | $18.64 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111576502 | CMS |
| Amgen Inc. | $6.51 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111576504 | CMS |
| Amgen Inc. | $120.83 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111576508 | CMS |
| Amgen Inc. | $6.50 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111576506 | CMS |
| Amgen Inc. | $8.29 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111576510 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.28 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101279523 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.39 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101279563 | CMS |
| Lilly USA, LLC | $16.81 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136172268 | CMS |
| Lilly USA, LLC | $18.52 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136169849 | CMS |
| Lilly USA, LLC | $96.67 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136157719 | CMS |
| Lilly USA, LLC | $19.35 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136172270 | CMS |
| Novartis Pharmaceuticals Corporation | $16.82 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086866497 | CMS |
| Novartis Pharmaceuticals Corporation | $13.97 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086866499 | CMS |
| Novo Nordisk Inc | $16.52 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096753469 | CMS |
| Novo Nordisk Inc | $18.95 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097693276 | CMS |
| Novo Nordisk Inc | $18.58 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096941023 | CMS |
| Novo Nordisk Inc | $21.31 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097301205 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.